SCHEMBL417178

SCHEMBL417178

C[C@H](N)c1ccncc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL225809 1.00
SCHEMBL2888206 1.00
Hydrochloric Acid SCHEMBL28802865 0.97 ROCK2 (0.53)
Hydrochloric Acid SCHEMBL14759581 0.97 ROCK2 (0.53)
Hydrochloric Acid SCHEMBL6432778 0.97 ROCK2 (0.53)
Hydrochloric Acid SCHEMBL2750606 0.97 ROCK2 (0.53)
Hydrochloric Acid SCHEMBL1002182 0.97 ROCK2 (0.53)
SCHEMBL8221139 0.85 ROCK2 (0.50)
SCHEMBL9931515 0.85 ROCK2 (0.50)
SCHEMBL21877119 0.85 ROCK2 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119431312-A Enzymatic serum albumin fluorescent probe and synthesis and application thereof 河北大学 2025-02-14 CN claimed
CN-119119035-A RIPK1 kinase target inhibitor and preparation method and application thereof 中山大学 2024-12-13 CN claimed
CN-109311850-B Imidazolone compounds as human neutrophil elastase inhibitors 奇斯药制品公司 2021-11-19 CN claimed
EP-3464273-B9 IMIDAZOLONE COMPOUNDS AS HUMAN NEUTROPHIL ELASTASE INHIBITORS CHIESI FARM SPA (IT) 2020-10-21 EP claimed
EP-3464273-B1 IMIDAZOLONE COMPOUNDS AS HUMAN NEUTROPHIL ELASTASE INHIBITORS CHIESI FARM SPA (IT) 2020-04-08 EP claimed
CN-109311850-A Imidazoquinolone compounds as people's inhibitors of neutrophil elastase 奇斯药制品公司 2019-02-05 CN claimed
US-20180009787-A1 NOVEL COMPOUNDS CHIESI FARMACEUTICI S.P.A. (IT) 2018-01-11 US claimed
US-9802919-B1 Compounds CHIESI FARMACEUTICI S.P.A. (IT) 2017-10-31 US claimed
US-12527779-B2 Prostaglandin E2 (PGE2) EP4 receptor antagonists DOMAIN THERAPEUTICS (FR) 2026-01-20 US disclosed
CN-119431312-B Enzymatic serum albumin fluorescent probe and synthesis and application thereof 河北大学 2025-09-26 CN disclosed
CN-119431312-A Enzymatic serum albumin fluorescent probe and synthesis and application thereof 河北大学 2025-02-14 CN disclosed
CN-119431225-A Dion-Jacobson two-dimensional organic-inorganic hybrid chiral perovskite single crystal and preparation method and application thereof 河南大学 2025-02-14 CN disclosed
CN-119431312-A Enzymatic serum albumin fluorescent probe and synthesis and application thereof 河北大学 2025-02-14 CN disclosed
CN-119119035-A RIPK1 kinase target inhibitor and preparation method and application thereof 中山大学 2024-12-13 CN disclosed
US-20050107419-A1 Condensed heterocyclic compounds as calcitonin agonists SMITHKLINE BEECHAM CORPORATION 2005-05-19 US disclosed
EP-1320540-A2 PEPTIDOMIMETIC PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2003-06-25 EP disclosed
US-6420398-B2 FOR TREATING AUTOIMMUNE DISEASES SUCH AS RHEUMATOID ARTHRITIS; 4-(3-(2-(ACETYLTHIO)ETHYL)-3-(2-CYCLOHEXYLETHYL)-UREIDOMETHYL)-1 -METHYLPYRIDINIUM IODIDE, FOR EXAMPLE; INHIBIT PRODUCTION OF TUMOR NECROSIS FACTOR ALPHA (TNF-A) SANTEN PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 US disclosed
WO-2002018369-A2 PEPTIDOMIMETIC PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2002-03-07 WO disclosed
US-20010041725-A1 Novel urea derivatives having nitrogen aromatic heterocycle SANTEN PHARMACEUTICAL CO., LTD. (JP) 2001-11-15 US disclosed
EP-1103543-A1 NOVEL UREA DERIVATIVES BEARING NITROGENOUS AROMATIC HETEROCYCLES SANTEN PHARMACEUTICAL CO., LTD. (JP) 2001-05-30 EP disclosed